BETHESDA, Md. -- Chindex International Inc., which sells medical products in China, said Monday its second-quarter profit fell as revenue remained flat and taxes rose.

Chindex earned $538,000, or 3 cents per share, down from profit of $862,000, or 5 cents per share, during the same period a year prior. Revenue remained flat at $38.1 million.

Product sales fell 10 percent to $17.1 million. Health care services revenue rose 10 percent to $21 million.

Chindex's income tax provision quadrupled from last year to about $1 million.

"Our second quarter reflects continued growth in the Healthcare Services division, offset by disruption related to construction at our Beijing facility," said President and CEO Roberta Lipson, in a statement.

She said the medical products unit faced regulatory delays on high-value equipment purchases.

Shares of Chindex fell $4.01, or 24 percent, to $12.20 in morning trading. The stock has traded between $3.50 and $16.46 over the last 52 weeks.

Join the discussion

The Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. In order to post comments, you must be a registered user of MiamiHerald.com. Your username will show along with the comments you post. Thank you for taking the time to offer your thoughts.

     Showing: Oldest first Newest first Most-recommended first Least-recommended first

@Nyx.AuthorDisplayName@ wrote on @Nyx.PostedAtTime@:

@Nyx.repliedToText@

@Nyx.replyAnswerText@

Reply to this Comment @Nyx.Recommender@ @Nyx.AbuseReporter@